Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Sunshine Lake Pharma CoHKSE:06887 +3.00%15 Days Payable is 329.10 as of Dec. 2025, which is 3% below its 10-year median of 339.77. GuruFocus rates HKSE:06887 with a GF Score™ of 15/100. The stock has 2 warning signs investors should review. Among 923 Drug Manufacturers companies, Sunshine Lake Pharma Co ranks better than 93.17% on this metric.
The historical rank and industry rank for Sunshine Lake Pharma Co's Days Payable or its related term are showing as below:
HKSE:06887'
s Days Payable Range Over the Past 10 Years
Min: 223.81 Med: 339.77 Max: 417.32
Current: 396.48
During the past 4 years, Sunshine Lake Pharma Co's highest Days Payable was 417.32. The lowest was 223.81. And the median was 339.77.
HKSE:06887's Days Payable is ranked better than 93.17% of 923
companies
in the Drug Manufacturers industry
Industry Median: 88.47
vs HKSE:06887: 396.48
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Sunshine Lake Pharma Co's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Sunshine Lake Pharma Co Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Sunshine Lake Pharma Co's Days Payable distribution charts can be found below:
* The bar in red indicates where Sunshine Lake Pharma Co's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Sunshine Lake Pharma Co's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Sunshine Lake Pharma Co (HKSE:06887) has a Days Payable of 329.10 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sunshine Lake Pharma Co and its competitors. This is near median its historical median of 339.77. Over the past decade, Sunshine Lake Pharma Co's Days Payable has ranged from 223.81 to 417.32. According to the industry distribution chart, Sunshine Lake Pharma Co ranks #63 out of 923 companies in the Drug Manufacturers industry, placing it in the top 6.8%.
Is Sunshine Lake Pharma Co's Days Payable too high?
Sunshine Lake Pharma Co's current Days Payable of 329.10 is near median its 10-year median of 339.77. Over the past 10 years, this metric has ranged from a low of 223.81 to a high of 417.32. The Drug Manufacturers industry median Days Payable is 88.47. Sunshine Lake Pharma Co's value of 329.10 is 272% above this industry median. Based on the distribution chart, Sunshine Lake Pharma Co ranks #63 out of 923 companies in the Drug Manufacturers industry, which is in the top quartile — a strong position relative to peers. Overall, Sunshine Lake Pharma Co has a GF Score™ of 15/100, reflecting its overall financial health beyond just this single metric.
How does Sunshine Lake Pharma Co's Days Payable compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Sunshine Lake Pharma Co ranks #63 out of 923 companies for Days Payable. This places Sunshine Lake Pharma Co in the top 7% of its industry — outperforming the majority of peers. The industry median Days Payable is 88.47. Sunshine Lake Pharma Co's value of 329.10 is 272% above this benchmark. Historically, Sunshine Lake Pharma Co's own Days Payable has ranged from 223.81 to 417.32 over the past decade. While the company's 10-year median is 339.77 vs. the industry median of 88.47, Sunshine Lake Pharma Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 88.47, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Sunshine Lake Pharma Co's current Days Payable of 329.10 is 272% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Sunshine Lake Pharma Co and its competitors. For the Drug Manufacturers industry, the median Days Payable is 88.47 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Sunshine Lake Pharma Co's current Days Payable is 329.10, which is near median its own 10-year median of 339.77. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Sunshine Lake Pharma Co stock overvalued right now?
Sunshine Lake Pharma Co (HKSE:06887) has a current Days Payable of 329.10. The current Days Payable is 329.10, which is near median its 10-year median of 339.77 and 272% above the Drug Manufacturers industry median of 88.47. Sunshine Lake Pharma Co's overall GF Score™ is 15/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Sunshine Lake Pharma Co (HKSE:06887), the current Days Payable is 329.10 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Sunshine Lake Pharma Co Ltd is a vertically integrated pharmaceutical company principally engaged in the research and development, manufacturing and sales of pharmaceuticals. It is focused on therapeutic areas of infectious diseases, chronic diseases and oncology. The company's revenue is mainly derived from sales of pharmaceutical products to distributors in the PRC.
15GF Score
Get the complete analysis for HKSE:06887
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:06887 has been successfully added to your 
